Mohammed A. Elbahloul: Every Minute Counts in STEMI Revascularization
Mohammed A. Elbahloul, Guest Editor at Plos One, shared a post on LinkedIn about a recent article he and her colleagues co-authored, published in Cardiovascular Interventions logo Journal, adding:
”I’m pleased to share that our manuscript, ‘Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials,’ has been published in Circulation: Cardiovascular Interventions (IF: 7.4).
I would like to express my sincere gratitude to my co-authors and mentors for their invaluable contributions and support throughout this work.
Key Findings:
- Primary Outcome: In hemodynamically stable patients with STEMI and multivessel disease, an immediate complete revascularization (ICR) strategy may be associated with an increased risk of short-term cardiac death compared with staged complete revascularization (SCR).
- Mortality Trends: Based on the current evidence, a potential increase in both early and late all-cause mortality with ICR cannot be excluded.
- Secondary Endpoints: No significant differences were observed between ICR and SCR in myocardial infarction, repeat revascularization, stent thrombosis, stroke, or major bleeding.
- Clinical Implications: While some uncertainty remains, these findings support a staged complete revascularization strategy for most patients with STEMI and multivessel disease.”
Title: Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials
Authors: Mohammed A. Elbahloul, Shrouk Ramadan, Eman E. Labeeb, Shahed Aldalahmeh, Ahella Ismail A. Mousa, Ahmed Elazab, Ahmed N. Mohamed, Ahmad Elashery, Mehiar O. El-Hamdani, Carl J. Lavie, Gregg W. Stone
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!